Monday, May 7, 2012

Nature Medicine Contents: May 2012 Volume 18 Number 5 pp 631-830

Nature Medicine


Advertisement
NOW OPEN ACCESS

EMBO Molecular Medicine - understanding disease

Impact Factor: 8.8 (2010, Thomson Reuters)
"We are excited to be able to provide unrestricted access to rigorously peer-reviewed translational research to researchers, clinicians and the public", Prof. Stefanie Dimmeler, Chief Editor.

FREE content at http://www.embomolmed.org
Experience EMBO'S transparent peer-review
TABLE OF CONTENTS

May 2012 Volume 18, Issue 5

Focus
Podcast
Editorial
News
Book Review
Correspondence
News and Views
Community Corner
Between Bedside and Bench
Research Highlights
Reviews
Articles
Letters
Technical Reports
Advertisement


Academy of Military Medical Sciences - Celebrating 60 years of research at one of China's leading organizations for medical science.

The Academy of Military Medical Sciences (AMMS) in Beijing has developed beyond its military heritage to become a world leader in medical science with a string of achievements in both military and civilian applications that have resonated around the globe. Find out more about the AMMS in Part 3 of the five-part series of this special sponsor feature on nature.com.


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Podcast

Advertisement
Efficacy and Mechanism Evaluation programme Commissioned call for proposals:

Retinal diseases
Diagnosis or Assessment of Infection

The deadline for applications is 1pm on 18 June 2012. More information on how to apply, the EME remit and the commissioning briefs can be found on the EME website.
Naturejobs
 
Advertisement
Nature Medicine
Focus on Asthma

This special issue of Nature Medicine features a collection of review articles that highlight recent advances in our understanding of asthma and point to the future directions in this dynamic area of research.

www.nature.com/nm/focus/asthma

Produced with support from:
Theravance, Inc
Almirall, S.A.
 

Nature Medicine Podcast 

Top

With bated breath 
Asthma unraveled, why hospital staph infections are so deadly and the latest on future treatments for sudden-onset hearing loss.
Listen Now

Editorial

Top

A fresh perspective on asthma p631
doi:10.1038/nm.2777
Abstract | Full Text | PDF

News

Top

Hopes soar as cholesterol plummets with new drug class p633
David Holmes
doi:10.1038/nm0512-633
Full Text | PDF

Malaria subsidy pilot soars, but some see turbulence ahead pp634 - 635
Amy Maxmen
doi:10.1038/nm0512-634
Full Text | PDF

Biologic drugs set to top 2012 sales p636
doi:10.1038/nm0512-636a
Full Text | PDF

Targeting hypoxia brings breath of fresh air to cancer therapy pp636 - 637
Melinda Wenner Moyer
doi:10.1038/nm0512-636b
Full Text | PDF

Billions of dollars for research at stake in health-reform case p637
John Otrompke
doi:10.1038/nm0512-637
Full Text | PDF

New biologic drugs get under the skin of psoriasis p638
Sarah C P Williams
doi:10.1038/nm0512-638
Full Text | PDF

Q&A

Straight talk with...Chen Zhu p639
doi:10.1038/nm0512-639
In April, China's Minister of Health Chen Zhu and his mentor, Wang Zhen-yi of the Shanghai Jiao Tong University School of Medicine, received the Albert Szent-Györgi Prize from the Washington, DC-based National Foundation for Cancer Research, in recognition for their work on acute promyelocytic leukemia. On that occasion, Victoria Aranda and Roxanne Khamsi asked Chen about his plans for cancer research and for improving stem cell regulation in China.
Abstract | Full Text | PDF

News in Brief

Biomedical briefing pp640 - 641
doi:10.1038/nm0512-640
Full Text | PDF

News Features

Sound medicine pp642 - 645
Elie Dolgin
doi:10.1038/nm0512-642
Everyone from rock stars to nonagenarians experiences hearing loss, but no drugs have ever been approved specifically to prevent or treat this problem. Recently, a handful of drug companies have started to make some noise, with a number of experimental compounds now in human trials. Elie Dolgin sounds off on what could be a multibillion dollar market.
Full Text | PDF

Innermost desires p644
doi:10.1038/nm0512-644
Full Text | PDF

Opinion

The WHO must reform for its own health p646
Tikki Pang and Laurie Garrett
doi:10.1038/nm0512-646
The World Health Organization (WHO) is facing an unprecedented crisis that threatens its position as the premier international health agency. To ensure its leading role, it must rethink its internal governance and revamp its financing mechanisms.
Full Text | PDF

Book Review

Top

Founding a new field p647
David Nathan reviews Dreams & Due Diligence: Till and McCulloch's Stem Cell Discovery and Legacy by Joe Sornberger
doi:10.1038/nm.2751
Full Text | PDF

Correspondence

Top

Activation of BK channels may not be required for bitter tastant-induced bronchodilation pp648 - 650
Cheng-Hai Zhang, Chen Chen, Lawrence M Lifshitz, Kevin E Fogarty, Min-Sheng Zhu and Ronghua ZhuGe
doi:10.1038/nm.2733
Full Text | PDF

Reply to: TAS2R-activation of BKca is essential for maximal physiological response in human airway smooth muscle pp650 - 651
Steven S An, Kathryn S Robinett, Deepak A Deshpande, Wayne C H Wang and Stephen B Liggett
doi:10.1038/nm.2734
Full Text | PDF

News and Views

Top

Mitochondria to the rescue pp653 - 654
Darwin J Prockop
doi:10.1038/nm.2769
A new study using a mouse model of lung diseases is the first demonstration in vivo that bone marrow-derived stromal cells can repair tissue injury through the transfer of mitochondria (pages 759-765). This suggests that rescue of injured cells through mitochondrial transfer may be an important process in many diseases.
Full Text | PDF

Germs gone wild pp654 - 656
Namiko Hoshi and Ruslan Medzhitov
doi:10.1038/nm.2767
The normally harmless behavior of bacteria in the intestinal tract is maintained by community structure and the integrity of host defenses. When either or both of these are compromised, a few disgruntled outcasts can cause a riot, taking down the whole neighborhood (pages 799-806).
Full Text | PDF

Metabolic surgery for type 2 diabetes pp656 - 658
David E Cummings
doi:10.1038/nm.2773
Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.
Full Text | PDF

Protective inflammasome activation in AMD pp658 - 660
Jing Chen and Lois E H Smith
doi:10.1038/nm.2761
Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly. AMD progression is associated with alterations in inflammatory pathways and the immune system. A new study identifies a protective role for inflammasomes in AMD, suggesting that inflammasome activation might be manipulated as a potential therapeutic strategy for this condition (pages 791-798).
Full Text | PDF

King of hearts: a splicing factor rules cardiac proteins pp660 - 661
Wolfgang A Linke and Sandra Bucker
doi:10.1038/nm.2762
Alternative splicing ensures the expression of functionally diverse proteins from individual genes; however, aberrant mRNA splicing is associated with various conditions, including heart disease. A recent study provides new mechanistic insights into heart failure by showing that a human cardiomyopathy-linked mutation in a cardiac splice factor affects post-transcriptional regulation, causing the expression of anomalous isoforms of a whole network of cardiac proteins (pages 766-773).
Full Text | PDF

Horizontal gene transfer boosts MRSA spreading pp662 - 663
Andre Kriegeskorte and Georg Peters
doi:10.1038/nm.2765
Mechanisms triggering methicillin-resistant Staphylococcus aureus (MRSA) epidemics are poorly understood. A recent study provides new evidence that horizontal gene transfer may be the culprit for the emergence of new resistant and virulent MRSA clones.
Full Text | PDF

Nature Medicine
JOBS of the week
PhD Studentship in Medicine
Cardiff University, School of Medicine
Post-Doctoral (W Wang) - Stem Cell Biology and Regenerative Medicine
Oklahoma Medical Research Foundation (OMRF)
Regenerative medicine of the oral mucosa
Unimore
Research Associate (Assistant Professor), General Internal Medicine
The University of Chicago (U of C)
Postdoctoral Fellow in Regenerative Medicine / Tissue Engineering
UTHealth | The University of Texas Health Science Center at Houston
More Science jobs from
Nature Medicine
EVENT
Cellular Signaling & Molecular Medicine
25.-29.05.12
Dubrovnik, Croatia
More science events from

Community Corner

Top

A step closer to effective transplant tolerance? pp664 - 665
doi:10.1038/nm.2770
Full Text | PDF

Between Bedside and Bench

Top

Topic: Guts over glory[mdash]why diets fail pp666 - 667
Rachel Larder and Stephen O'Rahilly
doi:10.1038/nm.2747
Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery[mdash]a surgical method to reduce or modify the gastrointestinal tract[mdash]was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.
Full Text | PDF

Topic: Metabolic insights from cutting the gut pp668 - 669
Keval Chandarana and Rachel L Batterham
doi:10.1038/nm.2748
Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery[mdash]a surgical method to reduce or modify the gastrointestinal tract[mdash]was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.
Full Text | PDF

Research Highlights

Top

Bone: Repairing joints | Metabolism: Calcium-mediated control | Brain: Bouncing back after brain injury | Cardiovascular disease: Lipoprotein traffic control | Immunology: Targeting IL-17 in psoriasis | New from NPG

Reviews

Top

Innate and adaptive immune responses in asthma pp673 - 683
Stephen T Holgate
doi:10.1038/nm.2731
Allergen sensitization is triggered by activating receptors of the innate arm of the immune system. This leads to the recruitment and activation of dendritic cells, which have a sentinel role in orchestrating the attendant adaptive response. Stephen Holgate highlights recent findings on how innate receptors are triggered, cellular sources of cytokines driving immune cell activation and the identification of new helper T cell subsets driving chronic allergic airway inflammation.
Abstract | Full Text | PDF

The airway epithelium in asthma pp684 - 692
Bart N Lambrecht and Hamida Hammad
doi:10.1038/nm.2737
The airway epithelium has a sentinel role in initiating allergic responses and asthma. Bart Lambrecht and Hamida Hammad review recent findings on how allergens activate epithelial cells and induce the production of cytokines and chemokines that recruit and activate dendritic cells and other cells of the innate immune system. Activation of these cell types promotes adaptive immune responses, which are, the authors argue, further maintained and perpetuated by their interaction with airway epithelial cells.
Abstract | Full Text | PDF

IgE and mast cells in allergic disease pp693 - 704
Stephen J Galli and Mindy Tsai
doi:10.1038/nm.2755
Both mast cells and IgE play crucial parts during the initiation and amplification of the allergic response during asthma, as well as during the tissue remodeling that occurs at the chronic stage. This review discusses how these two players can affect the development of asthma through independent and interdependent functions and the therapeutic implications for treating the clinical symptoms derived from allergic disease.
Abstract | Full Text | PDF

T cell homing to epithelial barriers in allergic disease pp705 - 715
Sabina A Islam and Andrew D Luster
doi:10.1038/nm.2760
Efficient trafficking of lymphocytes between the blood, lymphoid organs and peripheral tissues is essential for an effective immune response. Sabina Islam and Andrew Luster summarize recent findings on the regulation of leukocyte homing to the lungs, gut and skin in allergic inflammation and how leukocyte trafficking can be targeted clinically.
Abstract | Full Text | PDF

Asthma phenotypes: the evolution from clinical to molecular approaches pp716 - 725
Sally E Wenzel
doi:10.1038/nm.2678
The growing appreciation of asthma as a heterogeneous disease has led to the concept that asthma consists of multiple, different phenotypes, but now the challenge is to link underlying biology to phenotypes to allow a more robust classification and understanding of asthma. This review discusses the progress in defining asthma phenotypes and provides insights into how to apply this knowledge to provide more personalized approaches to treating asthma.
Abstract | Full Text | PDF

Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment pp726 - 735
Patrick G Holt and Peter D Sly
doi:10.1038/nm.2768
Viral infections can worsen episodes of allergic sensitization to allergens, putting the affected individuals, often children, at risk for developing persistent asthma during adult life. Understanding how the mechanisms mediating the antiviral response and driving allergic inflammation caused by allergens interact is crucial. This will provide insights into when and what player or molecule to target for treatment and prevention of asthma in children at the early stages of the disease.
Abstract | Full Text | PDF

Therapies for allergic inflammation: refining strategies to induce tolerance pp736 - 749
Cezmi A Akdis
doi:10.1038/nm.2754
This review outlines recent advances in the development of therapeutics that induce immune tolerance to treat asthma and allergic disease. It focuses on the distinct approaches of allergen-specific immunotherapy and biological immune modifiers and also highlights the possibility of combining these two strategies to harness the advantages of both types of therapy and address current unmet clinical needs associated with these conditions.
Abstract | Full Text | PDF

Articles

Top

Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology pp751 - 758
Bryan C Petersen, Alison L Budelsky, Alan P Baptist, Matthew A Schaller and Nicholas W Lukacs
doi:10.1038/nm.2735
Interleukin-25 (IL-25) is released from lung epithelial cells in response to allergen challenge and promotes type 2 immune responses and allergic airway inflammation. Nicholas Lukacs and his colleagues now report that IL-25 acts on a myeloid population in the lung. These cells represent a major source of IL-4 and IL-13, promote allergic lung inflammation and are steroid resistant. The frequency of IL-4- and IL-13-producing myeloid cells is increased in individuals with asthma, suggesting these cells may have a crucial role in the development of asthma.
Abstract | Full Text | PDF

Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury pp759 - 765
Mohammad Naimul Islam, Shonit R Das, Memet T Emin, Michelle Wei, Li Sun, Kristin Westphalen, David J Rowlands, Sadiqa K Quadri, Sunita Bhattacharya and Jahar Bhattacharya
doi:10.1038/nm.2736
Bone-marrow-derived stromal cells are known to protect against acute lung injury. Jahar Bhattacharya and colleagues now show that one way these cells offer such protection is to transfer their mitochondria to the injured lung epithelia to improve the bioenergetics of the recipient cells, thus probably allowing them to recover from injury more efficiently.
Abstract | Full Text | PDF

RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing pp766 - 773
Wei Guo, Sebastian Schafer, Marion L Greaser, Michael H Radke, Martin Liss, Thirupugal Govindarajan, Henrike Maatz, Herbert Schulz, Shijun Li, Amanda M Parrish, Vita Dauksaite, Padmanabhan Vakeel, Sabine Klaassen, Brenda Gerull, Ludwig Thierfelder, Vera Regitz-Zagrosek, Timothy A Hacker, Kurt W Saupe, G William Dec, Patrick T Ellinor, Calum A MacRae, Bastian Spallek, Robert Fischer, Andreas Perrot, Cemil Ozcelik, Kathrin Saar, Norbert Hubner and Michael Gotthardt
doi:10.1038/nm.2693
Alternative splicing affects the function of many cardiac proteins, including that of the sarcomeric protein titin. Wei Guo et al. now show that the gene RBM20, previously identified as mutated in some individuals with dilated cardiomyopathy, is a splicing factor that regulates the alternative splicing of the gene encoding titin and many other key cardiac genes.
Abstract | Full Text | PDF

Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia pp774 - 782
Tobias Eckle, Katherine Hartmann, Stephanie Bonney, Susan Reithel, Michel Mittelbronn, Lori A Walker, Brian D Lowes, Jun Han, Christoph H Borchers, Peter M Buttrick, Douglas J Kominsky, Sean P Colgan and Holger K Eltzschig
doi:10.1038/nm.2728
Tobias Eckle et al. describe a new regulatory circuit in the heart by which adenosine receptor signaling controls expression of the circadian protein Per2, which stabilizes the transcription factor Hif-1[alpha], promotes glycolytic metabolism and has cardioprotective effects. Exposing mice to intense light was able to stabilize Per2 in the heart and reduce cardiac injury after myocardial ischemia.
Abstract | Full Text | PDF

Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia pp783 - 790
Jiali Li, Jianmin Chen, Christopher L Ricupero, Ronald P Hart, Melanie S Schwartz, Alexander Kusnecov and Karl Herrup
doi:10.1038/nm.2709
Ataxia-telangiectasia is a multifaceted disease that includes motor dysfunction caused by neuron death in the cerebellum. Now, Karl Herrup and colleagues report that ATM, the gene that is lost in the disease, keeps HDAC4 out of the nucleus and in the cytoplasm to maintain cerebellar neuron health.
Abstract | Full Text | PDF

NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components pp791 - 798
Sarah L Doyle, Matthew Campbell, Ema Ozaki, Robert G Salomon, Andres Mori, Paul F Kenna, Gwyneth Jane Farrar, Anna-Sophia Kiang, Marian M Humphries, Ed C Lavelle, Luke A J O'Neill, Joe G Hollyfield and Peter Humphries
doi:10.1038/nm.2717
Age-related macular degeneration is a blinding disease associated with accumulation of aggregates called drusen in the retina. Now, Matthew Campbell and colleagues show that drusen can activate the inflammasome and that this activation protects against disease progression.
Abstract | Full Text | PDF

Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota pp799 - 806
Janelle S Ayres, Norver J Trinidad and Russell E Vance
doi:10.1038/nm.2729
The maintenance of a normal intestinal microbiota is associated with gut integrity and healthy immune responses. In this issue, Janelle Ayres and her colleagues report that disruption of the gut microbiome with antibiotics, coupled with gut injury, leads to the outgrowth of a pathogenic commensal bacterium and a sepsis-like disease. Their results show that the Naip5-Nlrc4 inflammasome is crucial for sensing the pathobiont and is a key factor in triggering the disease phenotype.
Abstract | Full Text | PDF

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer pp807 - 815
Elena Provasi, Pietro Genovese, Angelo Lombardo, Zulma Magnani, Pei-Qi Liu, Andreas Reik, Victoria Chu, David E Paschon, Lei Zhang, Jurgen Kuball, Barbara Camisa, Attilio Bondanza, Giulia Casorati, Maurilio Ponzoni, Fabio Ciceri, Claudio Bordignon, Philip D Greenberg, Michael C Holmes, Philip D Gregory, Luigi Naldini and Chiara Bonini
doi:10.1038/nm.2700
Engineered T cells expressing a tumor antigen specific T cell receptor (TCR) have shown promise for cancer immunotherapy. However, the introduced TCR chains can pair with the endogenous TCR chains in T cells, and in mice, these mismatched TCRs can cause a lethal autoimmune reaction. Provasi et al. now show that they can eliminate expression of the endogenous TCR chains using zinc finger nucleases and express only the desired exogenous TCR by lentiviral transduction. The resultant TCR-edited lymphocytes showed tumor specificity without the risk of off-target toxicity.
Abstract | Full Text | PDF

Letters

Top

MRSA epidemic linked to a quickly spreading colonization and virulence determinant pp816 - 819
Min Li, Xin Du, Amer E Villaruz, Binh An Diep, Decheng Wang, Yan Song, Yueru Tian, Jinhui Hu, Fangyou Yu, Yuan Lu and Michael Otto
doi:10.1038/nm.2692
A mobile genetic element[mdash]sasX[mdash]has a key role in the pathogenesis of methicillin-resistant Staphylococcus aureus (MRSA) infection. This rapidly spreading determinant of MRSA pathogenic success markedly enhances nasal colonization, lung disease and immune evasion.
First paragraph | Full Text | PDF

Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance pp820 - 823
Rebecca L Leshan, Megan Greenwald-Yarnell, Christa M Patterson, Ian E Gonzalez and Martin G Myers Jr
doi:10.1038/nm.2724
The adipocyte-derived hormone leptin acts on the brain to signal the long-term status of energy balance in the body. Martin Myers and his colleagues narrow down the population of neurons in the brain that actuate leptin's effects on food intake, and thus systemic energy balance, to a relatively small percentage of Nos1+ cells in the hypothalamus.
First paragraph | Full Text | PDF

Technical Reports

Top

Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides pp824 - 828
Katherina Siewert, Joachim Malotka, Naoto Kawakami, Hartmut Wekerle, Reinhard Hohlfeld and Klaus Dornmair
doi:10.1038/nm.2720
Finding new methods to define the target antigens recognized by MHC class I-restricted T cells is an unmet need. Katherina Siewert and her colleagues have developed a sensitive technique based on recombinatorial plasmid screening of T cell receptors (TCRs) isolated from individual T cells that overcomes many of the current limitations and enables the characterization of T cell antigens from most T cells, including those isolated from frozen biopsy samples by laser microdissection. The approach was validated using a well-characterized influenza virus-specific TCR, MHC and peptide combination.
Abstract | Full Text | PDF

A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle pp829 - 834
Moritz F Kircher, Adam de la Zerda, Jesse V Jokerst, Cristina L Zavaleta, Paul J Kempen, Erik Mittra, Ken Pitter, Ruimin Huang, Carl Campos, Frezghi Habte, Robert Sinclair, Cameron W Brennan, Ingo K Mellinghoff, Eric C Holland and Sanjiv S Gambhir
doi:10.1038/nm.2721
The ability to effectively assess tumor margins for brain tumor resection is a crucial factor in determining outcome in patients with brain tumors. Moritz Kircher and colleagues have developed a gold-silica nanoparticle that provides a triple-mode imaging capability of magnetic resonance, photoacoustic and Raman imaging, capitalizing on the complementary strengths of each modality for noninvasively delineating brain tumor margins both preoperatively and intraoperatively. The approach was tested in several mouse models, including one that recapitulates the infiltrating growth pattern of human gliomas.
Abstract | Full Text | PDF

Top
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: